ARCHIVES

Nancy Brinker Resigns As CEO of Komen

This article is from The Cancer Letter archive.

Vol. 38 No. 32 | August 10, 2012

Download PDF Visit The Full Archive

Related Articles

Concepts For Education Initiatives In Breast Ca Approved As RFA

July 9, 1993

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

UT Southwestern, M.D. Anderson Form Cancer Center In Dallas

May 5, 1995

New Chemoprevention Program Will Get “Whatever Money It Need;” Clinical Trials In New Division

July 25, 1980

Brachytherapy Better Than Surgery For Prostate Cancer

October 29, 2004

Administration Asking $233 Million Less For NCI In FY ’88 Than Congress Is Appropriating For ‘87

October 10, 1986